Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis.
about
Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.Pathogenesis and clinical spectrum of primary sclerosing cholangitis.Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis.The impact of fragility fractures on health-related quality of life in patients with primary sclerosing cholangitis.Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort.The features of mucosa-associated microbiota in primary sclerosing cholangitisFrequency and risk factors of primary sclerosing cholangitis among patients with inflammatory bowel disease in North-East of IranColorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?Epithelial markers of colorectal carcinogenesis in ulcerative colitis and primary sclerosing cholangitisPrimary sclerosing cholangitis: diagnosis, prognosis, and management.Risk of cancer, with special reference to extra-intestinal malignancies, in patients with inflammatory bowel disease.Long-term probability of and mortality from de novo malignancy after liver transplantation.Hepatobiliary associations with inflammatory bowel disease.Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.Has the risk of colorectal cancer in inflammatory bowel disease decreased?Inflammatory Bowel Disease Associated Colorectal Neoplasia.Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease.Who and how to screen for cancer in at-risk inflammatory bowel disease patients.Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.Histomorphological features and prognosis of colitis-associated colorectal cancer in patients with primary sclerosing cholangitis.Mesalamine, but Not Sulfasalazine, Reduces the Risk of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: An Agent-specific Systematic Review and Meta-analysis.Hepatic manifestations of inflammatory bowel diseases.Health-related quality of life among patients with primary sclerosing cholangitis.Does primary sclerosing cholangitis impact quality of life in patients with inflammatory bowel disease?Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis.Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis.Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel diseaseLarge bowel cancer in the setting of inflammatory bowel disease
P2860
Q26994675-4D35621C-B6D9-4B8C-AD52-FCA368ADB817Q30234950-3ADEF341-624C-4729-93EA-45660CFD151FQ33572623-CF696758-5D7C-43D6-B7A7-7BEA317C9345Q33948374-198C27A5-D277-4996-9BBE-291FF5159CEBQ35589931-DF77F3CF-08FA-4796-9E6E-A28ED2057297Q35750365-0DC54CD3-99D4-488C-A204-BCE9D2DF4E5CQ35917819-27916AF9-B7E7-4E16-A7C1-B3C5BE8D9415Q36006136-2F602C4B-2728-4501-9D16-F6EF39A4C99CQ36144484-16C0BA6B-E4C9-4530-8E4A-4B2C92A16CB1Q36770528-78E4072D-6CED-46C7-B44C-56A5B4F7859EQ36955053-DD82BAB4-24E6-40C5-85C3-F63DB04F86EBQ37439950-ECDDDD2E-9A48-4C7C-A758-8B300DEC1FB7Q37463619-955B328F-2ED0-4715-A2AE-92AFE0F4D676Q37636108-7ADADA9A-CE19-4C40-AE5B-E0E36A27A8EDQ37892612-7C81FD1E-8580-4139-BF6F-90372D353CD6Q38166711-5808048C-A39D-46EA-8A31-9A8EC519E46CQ38201722-B7240990-1819-44C5-8121-A31F5F883F18Q38210793-710110AC-F8C5-4A73-BC9C-8BAC231A29C9Q38319989-D9DE745B-20D3-4F81-94E7-8B270AB2B79AQ38356761-FFEAA4F1-2AD4-4D37-9E3B-C1B0E57C8F8EQ38523734-36F055A5-4C0C-4061-B1F8-18CBE127FC9FQ38571099-E73B973F-F16C-4AFC-9833-AE9A54BA483BQ38814158-ED5809F0-77FD-446B-B8FA-B21B2292A50DQ44825098-0E518DAC-B2F0-4166-AA28-7CE424C7546AQ49112084-31E5330E-02C2-4C76-BC9D-1CEBCF83139FQ51186907-BDBEF2CD-E144-46D5-9C72-1E8E9641DE4FQ51545353-B08F1387-6BBC-4330-B726-A0F4897AB96EQ57114735-3E36B0F5-0A40-4F29-8B22-0A7D21C4AB37Q57832665-44B5A772-7203-4801-97B4-16D25E0BEE32
P2860
Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Disease activity and cancer ri ...... rimary sclerosing cholangitis.
@en
Disease activity and cancer ri ...... rimary sclerosing cholangitis.
@nl
type
label
Disease activity and cancer ri ...... rimary sclerosing cholangitis.
@en
Disease activity and cancer ri ...... rimary sclerosing cholangitis.
@nl
prefLabel
Disease activity and cancer ri ...... rimary sclerosing cholangitis.
@en
Disease activity and cancer ri ...... rimary sclerosing cholangitis.
@nl
P2093
P2860
P921
P356
P1476
Disease activity and cancer ri ...... rimary sclerosing cholangitis.
@en
P2093
Emmanuel Tiret
Harry Sokol
Jacques Cosnes
Olivier Chazouilleres
Philippe Seksik
P2860
P304
P356
10.3748/WJG.14.3497
P407
P577
2008-06-01T00:00:00Z